These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 8244254

  • 21. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.
    Arase Y, Ikeda K, Suzuki F, Suzuki Y, Saitoh S, Kobayashi M, Akuta N, Someya T, Hosaka T, Sezaki H, Kobayashi M, Kumada H.
    Am J Med; 2006 Jan; 119(1):71.e9-16. PubMed ID: 16431195
    [Abstract] [Full Text] [Related]

  • 22. Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey.
    Yalcin K, Degertekin H, Bahcecioglu IH, Demir A, Aladag M, Yildirim B, Horasanli S, Ciftci S, Badur S.
    Infection; 2004 Feb; 32(1):24-9. PubMed ID: 15007739
    [Abstract] [Full Text] [Related]

  • 23. Viral pathogenesis of hepatocellular carcinoma in the United States.
    Liang TJ, Jeffers LJ, Reddy KR, De Medina M, Parker IT, Cheinquer H, Idrovo V, Rabassa A, Schiff ER.
    Hepatology; 1993 Dec; 18(6):1326-33. PubMed ID: 8244256
    [Abstract] [Full Text] [Related]

  • 24. HBV-DNA levels in HBsAg-positive blood donors and its relationship with liver histology.
    Nabuco LC, Villela-Nogueira CA, Perez RM, Ceci L, Pannain VL, Nogueira CM, Segadas-Soares JA, Coelho HS.
    J Clin Gastroenterol; 2007 Feb; 41(2):194-8. PubMed ID: 17245219
    [Abstract] [Full Text] [Related]

  • 25. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Bartolomé J, Pardo M, Carreño V.
    J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
    [Abstract] [Full Text] [Related]

  • 26. Export of intracellular HBsAg in chronic hepatitis B virus infection is related to viral replication.
    Lau JY, Bain VG, Davies SE, Alexander GJ, Williams R.
    Hepatology; 1991 Sep; 14(3):416-21. PubMed ID: 1714871
    [Abstract] [Full Text] [Related]

  • 27. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR.
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [Abstract] [Full Text] [Related]

  • 28. Prognostic significance of the hepatitis B virus-DNA concentration in patients after orthotopic liver transplantation.
    Zöllner B, Polywka S, Feucht HH, Martens H, Iske L, Oehler G, Laufs R.
    Hepatogastroenterology; 1994 Oct; 41(5):424-6. PubMed ID: 7851849
    [Abstract] [Full Text] [Related]

  • 29. Hepatitis B virus infection in patients with idiopathic liver disease.
    Liang TJ, Baruch Y, Ben-Porath E, Enat R, Bassan L, Brown NV, Rimon N, Blum HE, Wands JR.
    Hepatology; 1991 Jun; 13(6):1044-51. PubMed ID: 2050320
    [Abstract] [Full Text] [Related]

  • 30. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
    Kumar GT, Kazim SN, Kumar M, Hissar S, Chauhan R, Basir SF, Sarin SK.
    J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
    [Abstract] [Full Text] [Related]

  • 31. Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases.
    Georgiadou SP, Zachou K, Rigopoulou E, Liaskos C, Mina P, Gerovasilis F, Makri E, Dalekos GN.
    J Viral Hepat; 2004 Jul; 11(4):358-65. PubMed ID: 15230859
    [Abstract] [Full Text] [Related]

  • 32. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure.
    Abdelmalek MF, Pasha TM, Zein NN, Persing DH, Wiesner RH, Douglas DD.
    Liver Transpl; 2003 Dec; 9(12):1253-7. PubMed ID: 14625824
    [Abstract] [Full Text] [Related]

  • 33. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.
    Tanaka T, Inoue K, Hayashi Y, Abe A, Tsukiyama-Kohara K, Nuriya H, Aoki Y, Kawaguchi R, Kubota K, Yoshiba M, Koike M, Tanaka S, Kohara M.
    J Med Virol; 2004 Feb; 72(2):223-9. PubMed ID: 14695663
    [Abstract] [Full Text] [Related]

  • 34. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.
    Yuen MF, Wong DK, Sablon E, Tse E, Ng IO, Yuan HJ, Siu CW, Sander TJ, Bourne EJ, Hall JG, Condreay LD, Lai CL.
    Hepatology; 2004 Jun; 39(6):1694-701. PubMed ID: 15185311
    [Abstract] [Full Text] [Related]

  • 35. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group.
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [Abstract] [Full Text] [Related]

  • 36. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area.
    Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Berthelot P, Bréchot C.
    Hepatology; 1993 Jan; 17(1):20-9. PubMed ID: 8380790
    [Abstract] [Full Text] [Related]

  • 37. Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection.
    Sakugawa H, Nakasone H, Nakayoshi T, Kawakami Y, Yamashiro T, Maeshiro T, Kinjo F, Saito A, Zukeran H.
    J Med Virol; 2001 Nov; 65(3):478-84. PubMed ID: 11596082
    [Abstract] [Full Text] [Related]

  • 38. Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study.
    Obika M, Shinji T, Fujioka S, Terada R, Ryuko H, Lwin AA, Shiraha H, Koide N.
    Intervirology; 2008 Nov; 51(1):59-68. PubMed ID: 18349544
    [Abstract] [Full Text] [Related]

  • 39. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H, Ayola B, Lok AS.
    Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
    [Abstract] [Full Text] [Related]

  • 40. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z, Mor E, Shapira Z, Tur-Kaspa R.
    Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.